Industry Research Reports

Home > Reports > Service & Software > Single-Cell Multi-Omics Analysis Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Single-Cell Multi-Omics Analysis Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-18

Pages: 127 Pages

Report ld: 6977912

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Single-Cell Multi-Omics Analysis Platform Market Size(US$)

CAGR 2026-2032

18.3%

Market Size,2032

USD 12,743

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 4,649 million

Market Forecast in 2032(Value)

US$ 12,743 million

CAGR

18.3%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Single-Cell Multi-Omics Analysis Platform was estimated to be worth US$ 3930 million in 2025 and is projected to reach US$ 12743 million, growing at a CAGR of 18.3% from 2026 to 2032.

Single-cell multi-omics analysis platforms are integrated technology systems that jointly capture, sequence, and computationally analyze two or more molecular layers, such as the genome, transcriptome, epigenome, proteome, and immune receptor repertoire, from individual cells or nuclei. Products typically combine single-cell isolation or barcoding instruments, reagents and consumables, library preparation workflows, data-processing software, and visualization tools to resolve cellular heterogeneity, rare cell populations, and molecular regulatory relationships. The blended gross margin is approximately 65%.

Research on tumor heterogeneity, immune microenvironments, cell therapy product characterization, and complex disease mechanisms is moving from single-transcriptome measurements toward multimodal profiling. Pharmaceutical companies seek genotype, phenotype, and functional-state information from limited samples, while research institutions prioritize cell atlas construction and rare-population detection. These needs are expanding the market from exploratory experiments to larger, standardized programs.

Competition centers on cell-capture efficiency, multiplet rate, number of measurable omic layers, cell throughput, sequencing cost, and analysis automation. Droplet microfluidics remains mainstream, while combinatorial indexing and instrument-free reagent workflows are reducing capital requirements. Leading suppliers are building closed ecosystems across instruments, reagents, antibody tags, cloud analytics, and databases, with open protocols and cross-platform data compatibility becoming key upgrade priorities.

Research institutions, core facilities, and biopharmaceutical companies in North America and Europe remain the main customers, while China and the wider Asia-Pacific region are expanding through local sequencing platforms, clinical research, and cell therapy development. Opportunities include high-throughput fixed-sample workflows, longitudinal cohorts, drug-response profiling, and training data for AI models. Key risks include sample-preparation standardization, batch effects, data-storage costs, algorithm interpretability, and volatility in research budgets.

This report provides a comprehensive view of the global market for Single-Cell Multi-Omics Analysis Platform, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Single-Cell Multi-Omics Analysis Platform market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Single-Cell Multi-Omics Analysis Platform.

MARKET SEGMENTATION

By Company

10x Genomics
BD
Illumina
Parse Biosciences
Mission Bio
BioLegend
Singleron Biotechnologies
MGI Tech
BioSkryb Genomics
Scale Biosciences
Takara Bio
Cellenion
Dolomite Bio
Partek
BioTuring
QIAGEN
ROSALIND
CS Genetics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Transcriptome and Epigenome Platforms
Transcriptome and Proteome Platforms
Genome and Transcriptome Platforms
Genome and Proteome Platforms
Three-or-More-Omics Platforms
Other Multi-Omics Platforms

Segment by Application

Disease Mechanism Research
Drug Target and Biomarker Discovery
Cell and Gene Therapy Characterization
Clinical and Translational Research
Cell Atlas and Developmental Biology
Other Life Science Research

Segment by Category

Droplet Microfluidic Platforms
Microwell or Nanowell Platforms
Combinatorial Indexing Platforms
Plate-Based Dispensing Platforms
Other or Hybrid Platforms

Segment by Division

Low Throughput (≤1,000 Cells per Run)
Medium Throughput (1,001–10,000 Cells per Run)
High Throughput (10,001–100,000 Cells per Run)
Ultra-High Throughput (>100,000 Cells per Run)

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Single-Cell Multi-Omics Analysis Platform companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Single-Cell Multi-Omics Analysis Platform revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Single-Cell Multi-Omics Analysis Platform revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Single-Cell Multi-Omics Analysis Platform Product Introduction

1.2 Global Single-Cell Multi-Omics Analysis Platform Market Size Forecast (2021–2032)

1.3 Single-Cell Multi-Omics Analysis Platform Market Trends & Drivers

1.3.1 Single-Cell Multi-Omics Analysis Platform Industry Trends

1.3.2 Single-Cell Multi-Omics Analysis Platform Market Drivers & Opportunities

1.3.3 Single-Cell Multi-Omics Analysis Platform Market Challenges

1.3.4 Single-Cell Multi-Omics Analysis Platform Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Single-Cell Multi-Omics Analysis Platform Players Revenue Ranking (2025)

2.2 Global Single-Cell Multi-Omics Analysis Platform Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Single-Cell Multi-Omics Analysis Platform Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Single-Cell Multi-Omics Analysis Platform

2.6 Single-Cell Multi-Omics Analysis Platform Market Competitive Analysis

2.6.1 Single-Cell Multi-Omics Analysis Platform Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Single-Cell Multi-Omics Analysis Platform Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Single-Cell Multi-Omics Analysis Platform revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Single-Cell Multi-Omics Analysis Platform Market Classification

3.1 Introduction by Type

3.1.1 Transcriptome and Epigenome Platforms

3.1.2 Transcriptome and Proteome Platforms

3.1.3 Genome and Transcriptome Platforms

3.1.4 Genome and Proteome Platforms

3.1.5 Three-or-More-Omics Platforms

3.1.6 Other Multi-Omics Platforms

3.1.7 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type

3.1.7.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type (2021 vs 2025 vs 2032)

3.1.7.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value, by Type (2021–2032)

3.1.7.3 Global Single-Cell Multi-Omics Analysis Platform Sales Value, by Type (%), 2021–2032

3.2 Introduction by Cell Isolation Method

3.2.1 Droplet Microfluidic Platforms

3.2.2 Microwell or Nanowell Platforms

3.2.3 Combinatorial Indexing Platforms

3.2.4 Plate-Based Dispensing Platforms

3.2.5 Other or Hybrid Platforms

3.2.6 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Cell Isolation Method

3.2.6.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Cell Isolation Method (2021 vs 2025 vs 2032)

3.2.6.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value, by Cell Isolation Method (2021–2032)

3.2.6.3 Global Single-Cell Multi-Omics Analysis Platform Sales Value, by Cell Isolation Method (%), 2021–2032

3.3 Introduction by Processing Throughput

3.3.1 Low Throughput (≤1,000 Cells per Run)

3.3.2 Medium Throughput (1,001–10,000 Cells per Run)

3.3.3 High Throughput (10,001–100,000 Cells per Run)

3.3.4 Ultra-High Throughput (>100,000 Cells per Run)

3.3.5 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Processing Throughput

3.3.5.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Processing Throughput (2021 vs 2025 vs 2032)

3.3.5.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value, by Processing Throughput (2021–2032)

3.3.5.3 Global Single-Cell Multi-Omics Analysis Platform Sales Value, by Processing Throughput (%), 2021–2032

3.4 Introduction by Delivery Format

3.4.1 Integrated Instrument Platforms

3.4.2 Reagent Kit Platforms

3.4.3 On-Premise Software Platforms

3.4.4 Cloud Software Platforms

3.4.5 Analysis Service Platforms

3.4.6 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Delivery Format

3.4.6.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Delivery Format (2021 vs 2025 vs 2032)

3.4.6.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value, by Delivery Format (2021–2032)

3.4.6.3 Global Single-Cell Multi-Omics Analysis Platform Sales Value, by Delivery Format (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Disease Mechanism Research

4.1.2 Drug Target and Biomarker Discovery

4.1.3 Cell and Gene Therapy Characterization

4.1.4 Clinical and Translational Research

4.1.5 Cell Atlas and Developmental Biology

4.1.6 Other Life Science Research

4.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application

4.2.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (2021–2032)

4.2.3 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region

5.1.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (2021–2026)

5.1.3 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (2027–2032)

5.1.4 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

5.2.2 North America Single-Cell Multi-Omics Analysis Platform Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

5.3.2 Europe Single-Cell Multi-Omics Analysis Platform Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

5.4.2 Asia Pacific Single-Cell Multi-Omics Analysis Platform Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

5.5.2 South America Single-Cell Multi-Omics Analysis Platform Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

5.6.2 Middle East & Africa Single-Cell Multi-Omics Analysis Platform Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Single-Cell Multi-Omics Analysis Platform Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

6.3 United States

6.3.1 United States Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

6.3.2 United States Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Single-Cell Multi-Omics Analysis Platform Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

6.4.2 Europe Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Single-Cell Multi-Omics Analysis Platform Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

6.5.2 China Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

6.5.3 China Single-Cell Multi-Omics Analysis Platform Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

6.6.2 Japan Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Single-Cell Multi-Omics Analysis Platform Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

6.7.2 South Korea Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Single-Cell Multi-Omics Analysis Platform Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

6.8.2 Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Single-Cell Multi-Omics Analysis Platform Sales Value, 2021–2032

6.9.2 India Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

6.9.3 India Single-Cell Multi-Omics Analysis Platform Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 10x Genomics

7.1.1 10x Genomics Profile

7.1.2 10x Genomics Main Business

7.1.3 10x Genomics Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.1.4 10x Genomics Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.1.5 10x Genomics Recent Developments

7.2 BD

7.2.1 BD Profile

7.2.2 BD Main Business

7.2.3 BD Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.2.4 BD Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.2.5 BD Recent Developments

7.3 Illumina

7.3.1 Illumina Profile

7.3.2 Illumina Main Business

7.3.3 Illumina Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.3.4 Illumina Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.3.5 Illumina Recent Developments

7.4 Parse Biosciences

7.4.1 Parse Biosciences Profile

7.4.2 Parse Biosciences Main Business

7.4.3 Parse Biosciences Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.4.4 Parse Biosciences Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.4.5 Parse Biosciences Recent Developments

7.5 Mission Bio

7.5.1 Mission Bio Profile

7.5.2 Mission Bio Main Business

7.5.3 Mission Bio Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.5.4 Mission Bio Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.5.5 Mission Bio Recent Developments

7.6 BioLegend

7.6.1 BioLegend Profile

7.6.2 BioLegend Main Business

7.6.3 BioLegend Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.6.4 BioLegend Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.6.5 BioLegend Recent Developments

7.7 Singleron Biotechnologies

7.7.1 Singleron Biotechnologies Profile

7.7.2 Singleron Biotechnologies Main Business

7.7.3 Singleron Biotechnologies Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.7.4 Singleron Biotechnologies Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.7.5 Singleron Biotechnologies Recent Developments

7.8 MGI Tech

7.8.1 MGI Tech Profile

7.8.2 MGI Tech Main Business

7.8.3 MGI Tech Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.8.4 MGI Tech Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.8.5 MGI Tech Recent Developments

7.9 BioSkryb Genomics

7.9.1 BioSkryb Genomics Profile

7.9.2 BioSkryb Genomics Main Business

7.9.3 BioSkryb Genomics Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.9.4 BioSkryb Genomics Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.9.5 BioSkryb Genomics Recent Developments

7.10 Scale Biosciences

7.10.1 Scale Biosciences Profile

7.10.2 Scale Biosciences Main Business

7.10.3 Scale Biosciences Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.10.4 Scale Biosciences Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.10.5 Scale Biosciences Recent Developments

7.11 Takara Bio

7.11.1 Takara Bio Profile

7.11.2 Takara Bio Main Business

7.11.3 Takara Bio Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.11.4 Takara Bio Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.11.5 Takara Bio Recent Developments

7.12 Cellenion

7.12.1 Cellenion Profile

7.12.2 Cellenion Main Business

7.12.3 Cellenion Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.12.4 Cellenion Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.12.5 Cellenion Recent Developments

7.13 Dolomite Bio

7.13.1 Dolomite Bio Profile

7.13.2 Dolomite Bio Main Business

7.13.3 Dolomite Bio Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.13.4 Dolomite Bio Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.13.5 Dolomite Bio Recent Developments

7.14 Partek

7.14.1 Partek Profile

7.14.2 Partek Main Business

7.14.3 Partek Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.14.4 Partek Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.14.5 Partek Recent Developments

7.15 BioTuring

7.15.1 BioTuring Profile

7.15.2 BioTuring Main Business

7.15.3 BioTuring Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.15.4 BioTuring Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.15.5 BioTuring Recent Developments

7.16 QIAGEN

7.16.1 QIAGEN Profile

7.16.2 QIAGEN Main Business

7.16.3 QIAGEN Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.16.4 QIAGEN Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.16.5 QIAGEN Recent Developments

7.17 ROSALIND

7.17.1 ROSALIND Profile

7.17.2 ROSALIND Main Business

7.17.3 ROSALIND Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.17.4 ROSALIND Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.17.5 ROSALIND Recent Developments

7.18 CS Genetics

7.18.1 CS Genetics Profile

7.18.2 CS Genetics Main Business

7.18.3 CS Genetics Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

7.18.4 CS Genetics Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million), 2021–2026

7.18.5 CS Genetics Recent Developments

8 Industry Chain Analysis

8.1 Single-Cell Multi-Omics Analysis Platform Value Chain

8.2 Single-Cell Multi-Omics Analysis Platform Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Single-Cell Multi-Omics Analysis Platform Sales Model

8.5.2 Sales Channels

8.5.3 Single-Cell Multi-Omics Analysis Platform Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Single-Cell Multi-Omics Analysis Platform Market Trends

Table 2. Single-Cell Multi-Omics Analysis Platform Market Drivers & Opportunities

Table 3. Single-Cell Multi-Omics Analysis Platform Market Challenges

Table 4. Single-Cell Multi-Omics Analysis Platform Market Restraints

Table 5. Global Single-Cell Multi-Omics Analysis Platform Revenue by Company (US$ Million), 2021–2026

Table 6. Global Single-Cell Multi-Omics Analysis Platform Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Single-Cell Multi-Omics Analysis Platform Product Type

Table 9. Key Companies General Availability (GA) Timeline for Single-Cell Multi-Omics Analysis Platform

Table 10. Global Single-Cell Multi-Omics Analysis Platform Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Single-Cell Multi-Omics Analysis Platform revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Single-Cell Multi-Omics Analysis Platform Sales Market Share in Value by Type (2021–2026)

Table 17. Global Single-Cell Multi-Omics Analysis Platform Sales Market Share in Value by Type (2027–2032)

Table 18. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Cell Isolation Method: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Cell Isolation Method (US$ Million), 2021–2026

Table 20. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Cell Isolation Method (US$ Million), 2027–2032

Table 21. Global Single-Cell Multi-Omics Analysis Platform Sales Market Share in Value by Cell Isolation Method (2021–2026)

Table 22. Global Single-Cell Multi-Omics Analysis Platform Sales Market Share in Value by Cell Isolation Method (2027–2032)

Table 23. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Processing Throughput: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Processing Throughput (US$ Million), 2021–2026

Table 25. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Processing Throughput (US$ Million), 2027–2032

Table 26. Global Single-Cell Multi-Omics Analysis Platform Sales Market Share in Value by Processing Throughput (2021–2026)

Table 27. Global Single-Cell Multi-Omics Analysis Platform Sales Market Share in Value by Processing Throughput (2027–2032)

Table 28. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Delivery Format: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Delivery Format (US$ Million), 2021–2026

Table 30. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Delivery Format (US$ Million), 2027–2032

Table 31. Global Single-Cell Multi-Omics Analysis Platform Sales Market Share in Value by Delivery Format (2021–2026)

Table 32. Global Single-Cell Multi-Omics Analysis Platform Sales Market Share in Value by Delivery Format (2027–2032)

Table 33. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 34. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (US$ Million), 2021–2026

Table 35. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (US$ Million), 2027–2032

Table 36. Global Single-Cell Multi-Omics Analysis Platform Sales Market Share in Value by Application (2021–2026)

Table 37. Global Single-Cell Multi-Omics Analysis Platform Sales Market Share in Value by Application (2027–2032)

Table 38. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 39. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (US$ Million), 2021–2026

Table 40. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (US$ Million), 2027–2032

Table 41. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (%), 2021–2026

Table 42. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (%), 2027–2032

Table 43. Key Countries/Regions Single-Cell Multi-Omics Analysis Platform Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 44. Key Countries/Regions Single-Cell Multi-Omics Analysis Platform Sales Value, (US$ Million), 2021–2026

Table 45. Key Countries/Regions Single-Cell Multi-Omics Analysis Platform Sales Value, (US$ Million), 2027–2032

Table 46. 10x Genomics Basic Information List

Table 47. 10x Genomics Description and Business Overview

Table 48. 10x Genomics Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of 10x Genomics (2021–2026)

Table 50. 10x Genomics Recent Developments

Table 51. BD Basic Information List

Table 52. BD Description and Business Overview

Table 53. BD Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of BD (2021–2026)

Table 55. BD Recent Developments

Table 56. Illumina Basic Information List

Table 57. Illumina Description and Business Overview

Table 58. Illumina Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of Illumina (2021–2026)

Table 60. Illumina Recent Developments

Table 61. Parse Biosciences Basic Information List

Table 62. Parse Biosciences Description and Business Overview

Table 63. Parse Biosciences Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of Parse Biosciences (2021–2026)

Table 65. Parse Biosciences Recent Developments

Table 66. Mission Bio Basic Information List

Table 67. Mission Bio Description and Business Overview

Table 68. Mission Bio Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of Mission Bio (2021–2026)

Table 70. Mission Bio Recent Developments

Table 71. BioLegend Basic Information List

Table 72. BioLegend Description and Business Overview

Table 73. BioLegend Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of BioLegend (2021–2026)

Table 75. BioLegend Recent Developments

Table 76. Singleron Biotechnologies Basic Information List

Table 77. Singleron Biotechnologies Description and Business Overview

Table 78. Singleron Biotechnologies Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of Singleron Biotechnologies (2021–2026)

Table 80. Singleron Biotechnologies Recent Developments

Table 81. MGI Tech Basic Information List

Table 82. MGI Tech Description and Business Overview

Table 83. MGI Tech Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of MGI Tech (2021–2026)

Table 85. MGI Tech Recent Developments

Table 86. BioSkryb Genomics Basic Information List

Table 87. BioSkryb Genomics Description and Business Overview

Table 88. BioSkryb Genomics Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of BioSkryb Genomics (2021–2026)

Table 90. BioSkryb Genomics Recent Developments

Table 91. Scale Biosciences Basic Information List

Table 92. Scale Biosciences Description and Business Overview

Table 93. Scale Biosciences Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of Scale Biosciences (2021–2026)

Table 95. Scale Biosciences Recent Developments

Table 96. Takara Bio Basic Information List

Table 97. Takara Bio Description and Business Overview

Table 98. Takara Bio Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of Takara Bio (2021–2026)

Table 100. Takara Bio Recent Developments

Table 101. Cellenion Basic Information List

Table 102. Cellenion Description and Business Overview

Table 103. Cellenion Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of Cellenion (2021–2026)

Table 105. Cellenion Recent Developments

Table 106. Dolomite Bio Basic Information List

Table 107. Dolomite Bio Description and Business Overview

Table 108. Dolomite Bio Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of Dolomite Bio (2021–2026)

Table 110. Dolomite Bio Recent Developments

Table 111. Partek Basic Information List

Table 112. Partek Description and Business Overview

Table 113. Partek Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of Partek (2021–2026)

Table 115. Partek Recent Developments

Table 116. BioTuring Basic Information List

Table 117. BioTuring Description and Business Overview

Table 118. BioTuring Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of BioTuring (2021–2026)

Table 120. BioTuring Recent Developments

Table 121. QIAGEN Basic Information List

Table 122. QIAGEN Description and Business Overview

Table 123. QIAGEN Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 124. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of QIAGEN (2021–2026)

Table 125. QIAGEN Recent Developments

Table 126. ROSALIND Basic Information List

Table 127. ROSALIND Description and Business Overview

Table 128. ROSALIND Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 129. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of ROSALIND (2021–2026)

Table 130. ROSALIND Recent Developments

Table 131. CS Genetics Basic Information List

Table 132. CS Genetics Description and Business Overview

Table 133. CS Genetics Single-Cell Multi-Omics Analysis Platform Products, Services, and Solutions

Table 134. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of CS Genetics (2021–2026)

Table 135. CS Genetics Recent Developments

Table 136. Revenue (US$ Million) in Single-Cell Multi-Omics Analysis Platform Business of Company 40 (2021–2026)

Table 137. Company 40 Recent Developments

Table 138. Key Raw Materials Lists

Table 139. Key Suppliers of Raw Materials Lists

Table 140. Single-Cell Multi-Omics Analysis Platform Downstream Customers

Table 141. Single-Cell Multi-Omics Analysis Platform Distributors List

Table 142. Research Programs/Design for This Report

Table 143. Key Data Information from Secondary Sources

Table 144. Key Data Information from Primary Sources

List of Figures

Figure 1. Single-Cell Multi-Omics Analysis Platform Product Picture

Figure 2. Global Single-Cell Multi-Omics Analysis Platform Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 4. Single-Cell Multi-Omics Analysis Platform Report Years Considered

Figure 5. Global Single-Cell Multi-Omics Analysis Platform Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Single-Cell Multi-Omics Analysis Platform Revenue in 2025

Figure 7. Single-Cell Multi-Omics Analysis Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Transcriptome and Epigenome Platforms Picture

Figure 9. Transcriptome and Proteome Platforms Picture

Figure 10. Genome and Transcriptome Platforms Picture

Figure 11. Genome and Proteome Platforms Picture

Figure 12. Three-or-More-Omics Platforms Picture

Figure 13. Other Multi-Omics Platforms Picture

Figure 14. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Single-Cell Multi-Omics Analysis Platform Sales Value Market Share by Type, 2025 & 2032

Figure 16. Droplet Microfluidic Platforms Picture

Figure 17. Microwell or Nanowell Platforms Picture

Figure 18. Combinatorial Indexing Platforms Picture

Figure 19. Plate-Based Dispensing Platforms Picture

Figure 20. Other or Hybrid Platforms Picture

Figure 21. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Cell Isolation Method (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Single-Cell Multi-Omics Analysis Platform Sales Value Market Share by Cell Isolation Method, 2025 & 2032

Figure 23. Low Throughput (≤1,000 Cells per Run) Picture

Figure 24. Medium Throughput (1,001–10,000 Cells per Run) Picture

Figure 25. High Throughput (10,001–100,000 Cells per Run) Picture

Figure 26. Ultra-High Throughput (>100,000 Cells per Run) Picture

Figure 27. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Processing Throughput (US$ Million), 2021 vs 2025 vs 2032

Figure 28. Global Single-Cell Multi-Omics Analysis Platform Sales Value Market Share by Processing Throughput, 2025 & 2032

Figure 29. Integrated Instrument Platforms Picture

Figure 30. Reagent Kit Platforms Picture

Figure 31. On-Premise Software Platforms Picture

Figure 32. Cloud Software Platforms Picture

Figure 33. Analysis Service Platforms Picture

Figure 34. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Delivery Format (US$ Million), 2021 vs 2025 vs 2032

Figure 35. Global Single-Cell Multi-Omics Analysis Platform Sales Value Market Share by Delivery Format, 2025 & 2032

Figure 36. Product Picture of Disease Mechanism Research

Figure 37. Product Picture of Drug Target and Biomarker Discovery

Figure 38. Product Picture of Cell and Gene Therapy Characterization

Figure 39. Product Picture of Clinical and Translational Research

Figure 40. Product Picture of Cell Atlas and Developmental Biology

Figure 41. Product Picture of Other Life Science Research

Figure 42. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 43. Global Single-Cell Multi-Omics Analysis Platform Sales Value Market Share by Application, 2025 & 2032

Figure 44. North America Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 45. North America Single-Cell Multi-Omics Analysis Platform Sales Value by Country (%), 2025 vs 2032

Figure 46. Europe Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 47. Europe Single-Cell Multi-Omics Analysis Platform Sales Value by Country (%), 2025 vs 2032

Figure 48. Asia Pacific Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 49. Asia Pacific Single-Cell Multi-Omics Analysis Platform Sales Value by Subregion (%), 2025 vs 2032

Figure 50. South America Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 51. South America Single-Cell Multi-Omics Analysis Platform Sales Value by Country (%), 2025 vs 2032

Figure 52. Middle East & Africa Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 53. Middle East & Africa Single-Cell Multi-Omics Analysis Platform Sales Value by Country (%), 2025 vs 2032

Figure 54. Key Countries/Regions Single-Cell Multi-Omics Analysis Platform Sales Value (%), 2021–2032

Figure 55. United States Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 56. United States Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

Figure 57. United States Single-Cell Multi-Omics Analysis Platform Sales Value by Application (%), 2025 vs 2032

Figure 58. Europe Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 59. Europe Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

Figure 60. Europe Single-Cell Multi-Omics Analysis Platform Sales Value by Application (%), 2025 vs 2032

Figure 61. China Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 62. China Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

Figure 63. China Single-Cell Multi-Omics Analysis Platform Sales Value by Application (%), 2025 vs 2032

Figure 64. Japan Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 65. Japan Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

Figure 66. Japan Single-Cell Multi-Omics Analysis Platform Sales Value by Application (%), 2025 vs 2032

Figure 67. South Korea Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 68. South Korea Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

Figure 69. South Korea Single-Cell Multi-Omics Analysis Platform Sales Value by Application (%), 2025 vs 2032

Figure 70. Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 71. Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

Figure 72. Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value by Application (%), 2025 vs 2032

Figure 73. India Single-Cell Multi-Omics Analysis Platform Sales Value (US$ Million), 2021–2032

Figure 74. India Single-Cell Multi-Omics Analysis Platform Sales Value by Type (%), 2025 vs 2032

Figure 75. India Single-Cell Multi-Omics Analysis Platform Sales Value by Application (%), 2025 vs 2032

Figure 76. Single-Cell Multi-Omics Analysis Platform Value Chain

Figure 77. Single-Cell Multi-Omics Analysis Platform Cost Structure

Figure 78. Channels of Distribution (Direct Sales, and Distribution)

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Single-Cell Multi-Omics Analysis Platform in 2032? zhanKai

The global market size of Single-Cell Multi-Omics Analysis Platform in 2032 was 12743 Million USD.

What is the annual compound growth rate of the global Single-Cell Multi-Omics Analysis Platform market size from 2026 to 2032? shouQi

Which companies rank high in the global Single-Cell Multi-Omics Analysis Platform market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Single-Cell Multi-Omics Analysis Platform in 2026? shouQi

Related Reports

Global Single-Cell Multi-Omics Analysis Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Single-Cell Multi-Omics Analysis Platform market is projected to grow from US$ 3930 million in 2025 to US$ 12743 million by 2032, at a CAGR of 18.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-18
Pages: 159
USD 4900.00
(Single User License)
Global Single-Cell Multi-Omics Analysis Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Single-Cell Multi-Omics Analysis Platform market size was US$ 3930 million in 2025 and is forecast to reach a readjusted size of US$ 12743 million by 2032 with a CAGR of 18.3% during the forecast period 2026-2032.
Published Date: 2026-07-18
Pages: 126
USD 4250.00
(Single User License)
Global Single-Cell Multi-Omics Analysis Platform Market Research Report 2026
The global Single-Cell Multi-Omics Analysis Platform market was valued at US$ 3930 million in 2025 and is anticipated to reach US$ 12743 million by 2032, at a CAGR of 18.3% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 122
USD 2900.00
(Single User License)

Global Single-Cell Multi-Omics Analysis Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Single-Cell Multi-Omics Analysis Platform market is projected to grow from US$ 3930 million in 2025 to US$ 12743 million by 2032, at a CAGR of 18.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-18
Pages: 159
USD 4900.00 (Single User License)
Global Single-Cell Multi-Omics Analysis Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Single-Cell Multi-Omics Analysis Platform market size was US$ 3930 million in 2025 and is forecast to reach a readjusted size of US$ 12743 million by 2032 with a CAGR of 18.3% during the forecast period 2026-2032.
Published: 2026-07-18
Pages: 126
USD 4250.00 (Single User License)
Global Single-Cell Multi-Omics Analysis Platform Market Research Report 2026
The global Single-Cell Multi-Omics Analysis Platform market was valued at US$ 3930 million in 2025 and is anticipated to reach US$ 12743 million by 2032, at a CAGR of 18.3% from 2026 to 2032.
Published: 2026-07-18
Pages: 122
USD 2900.00 (Single User License)